Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Todos Medical Ltd (OP: TOMDF )

0.0010 +0.0001 (+11.11%)
Streaming Delayed Price Updated: 3:59 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,035,427
Open 0.0009
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0009
Today's Range 0.0009 - 0.0010
52wk Range 0.0007 - 0.0420
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Todos Medical Enters Into Letter of Intent for Provista Diagnostics to License PCR-based Sepsis Diagnostic Test AcuSept LDT Rights From Acumen Diagnostics
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19
Todos Medical Begins Trading on the OTC Pink Marketplace
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire

Performance

YTD
-89.25%
-89.25%
1 Month
-52.38%
-52.38%
3 Month
-88.76%
-88.76%
6 Month
-94.38%
-94.38%
1 Year
-94.95%
-94.95%

More News

Read More
Todos Medical Supports Long COVID Awareness Day
Via NewMediaWire
Exposures COVID-19
Todos Medical Enters Into Moratorium on Conversions Agreement With Convertible Note Holders
Via NewMediaWire
Todos Medical Provides Corporate Update
Via NewMediaWire
Todos Medical Initiates Validation Plan for PCR-based Avian Influenza A (H5N1, Bird Flu) Test at CLIA/CAP Testing Lab Provista Diagnostics
Via NewMediaWire
CapitalGainsReport: Today’s OTC Bounce Watchlist (TOMDF, PHIL, RGBP, AIAD)
Via News Direct
Exposures COVID-19
Todos Medical to Present at the RHK 2022 Disruptive Growth Conference
Via NewMediaWire
Todos Medicals 3CL Pharma Awarded Oral and Poster Presentations at World Antiviral Congress 2022
Via NewMediaWire
Todos Medical to Attend World Antiviral Congress
Via NewMediaWire
Todos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail Network
Via NewMediaWire
Todos Medical Announces Third Quarter 2022 Financial Results
Via NewMediaWire
Todos Medical to Host Third Quarter 2022 Earnings and Business Update Conference Call on November 15, 2022
Via NewMediaWire
Todos Medical Terminates Tollovid Products License & Distribution Agreement with T-Cell Protect Hellas S.A.
Via NewMediaWire
Todos Medical Announces BioFuture NYC 2022 Presentation
Via NewMediaWire
Most Active On The OTC Markets In September – A Look Back As October Comes To A Close
Via Benzinga
Todos Medical CLIA/CAP Lab Provista Submits Emergency Use Authorization Application for MonkeyPox PCR Test to US FDA
Via NewMediaWire
Exposures Product Safety
Todos Medical Provides Corporate Update
Via NewMediaWire
Exposures COVID-19
Todos Medical Announces Successful Pilot Launch of Suite of PCR Testing Services by CLIA/CAP Lab Provista Diagnostics
Via NewMediaWire
Exposures COVID-19
Todos Medical Receives Two Notices of Allowance from USPTO for AI-Based TBIA Pan-Cancer Blood Diagnostics Platform
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
Todos Medical Announces USPTO Trademark Notice of Allowance for 3CL Protease Biomarker Diagnostics TolloTest
Via NewMediaWire
Todos Medical Enters Into $50M Contract to Supply Tollovid and CBD Products to Retail Distributor Company Nerd Hemp
Via NewMediaWire
Topics Artificial Intelligence Supply Chain
Exposures Artificial Intelligence Supply Chain
Todos Medical Announces NFL Hall of Famer Michael Irvin as Tollovid Sports Ambassador for #TolloUp Campaign
Via NewMediaWire
Exposures COVID-19
Todos Medical Announces Preprint of Long COVID Case Study Participant with Confirmed Microclot and Hyperactivated Platelets who Benefitted from Tollovid
Via NewMediaWire
Exposures COVID-19
Todos Medical Initiates Validation Plan for PCR-based Polio Testing at CLIA/CAP Laboratory Provista Diagnostics
Via NewMediaWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.